Exact Mass: 264.0724826
Exact Mass Matches: 264.0724826
Found 174 metabolites which its exact mass value is equals to given mass value 264.0724826
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sulfamerazine
Sulfamerazine is only found in individuals that have used or taken this drug.It is a sulfanilamide that is used as an antibacterial agent. [PubChem]Sulfamerazine is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase (dihydrofolate synthetase). Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BA - Sulfonamides J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
gamma-Glutamyl-S-methylcysteine
gamma-Glutamyl-S-methylcysteine is found in garden onion. gamma-Glutamyl-S-methylcysteine is a constituent of many edible vegetable species Constituent of many edible vegetable species. gamma-Glutamyl-S-methylcysteine is found in garden onion, soft-necked garlic, and lima bean.
Methionyl-Aspartate
Methionyl-Aspartate is a dipeptide composed of methionine and aspartate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Aspartyl-Methionine
Aspartyl-Methionine is a dipeptide composed of aspartate and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
N-Acetylcystathionine
N-Acetylcystathionine is an amino-acid. It is found in the urine of patients with cystathioninuria which is an autosomal recessive phenotype with abnormal accumulcation of plasma cystathionine, leading to increased urinary excretion (PMID: 1793738) [HMDB] N-Acetylcystathionine is an amino-acid. It is found in the urine of patients with cystathioninuria which is an autosomal recessive phenotype with abnormal accumulcation of plasma cystathionine, leading to increased urinary excretion (PMID: 1793738).
2,2-Difluoro-n-(2-hydroxyethyl)-3-(2-nitro-1h-imidazol-1-yl)propanamide
3,3-Methylenebis(4-hydroxy-6-methyl-2H-pyran-2-one)
Acetic acid 2-oxo-5,6-dimethoxy-2H-1-benzopyran-7-yl ester
2,5-dihydroxy-3,8-dimethoxy-7-methylnaphtho-1,4-quinone|Nepenthone E
2-Propenoic acid, 3-[3,4-bis(acetyloxy)phenyl]-, (E)-
Tanshinlactone
Tanshinlactone is a natural product found in Salvia miltiorrhiza with data available.
sulfamerazine
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BA - Sulfonamides J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; INTERNAL_ID 1016
4-hydroxy-3-[(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-6-methylpyran-2-one
3,7,8-trihydroxy-3-methyl-1,4-dihydropyrano[4,3-b]chromen-10-one
4-hydroxy-3-[(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-6-methylpyran-2-one
Phenyl 1-hydroxy-2-naphthoate
CONFIDENCE standard compound; INTERNAL_ID 1074; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5147; ORIGINAL_PRECURSOR_SCAN_NO 5145 DATASET 20200303_ENTACT_RP_MIX505; CONFIDENCE standard compound; INTERNAL_ID 1074; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5844; ORIGINAL_PRECURSOR_SCAN_NO 5842 CONFIDENCE standard compound; INTERNAL_ID 1074; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5844; ORIGINAL_PRECURSOR_SCAN_NO 5842 CONFIDENCE standard compound; INTERNAL_ID 1074; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5882; ORIGINAL_PRECURSOR_SCAN_NO 5880 CONFIDENCE standard compound; INTERNAL_ID 1074; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5858; ORIGINAL_PRECURSOR_SCAN_NO 5855 CONFIDENCE standard compound; INTERNAL_ID 1074; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5940; ORIGINAL_PRECURSOR_SCAN_NO 5938 CONFIDENCE standard compound; INTERNAL_ID 1074; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5273; ORIGINAL_PRECURSOR_SCAN_NO 5272
4-hydroxy-3-[(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-6-methylpyran-2-one_major
Met-asp
A dipeptide formed from L-methionine and L-aspartic acid residues.
N-Benzyloxycarbonyl-2-oxoimidazoline-4-carboxylic acid
2-Naphthalenecarboxylicacid, 3-hydroxy-, phenyl ester
2-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)ISOINDOLINE-1,3-DIONE
C14H8N4O2 (264.06472279999997)
4-(2-chloroacetyl)-1,5-dimethyl-2-phenyl-pyrazol-3-one
3-AMINO-3-[5-(2-CHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID AMIDE
3-AMINO-3-[5-(3-CHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID AMIDE
(5-FLUORO-2-((4-FLUOROBENZYL)OXY)PHENYL)BORONIC ACID
(5-FLUORO-2-((2-FLUOROBENZYL)OXY)PHENYL)BORONIC ACID
(5-FLUORO-2-((3-FLUOROBENZYL)OXY)PHENYL)BORONIC ACID
Glycine, N-[2-[(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl ), disodium salt
2-(4-CHLOROPHENYL)-5-METHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
1-Naphthalenecarboxylic acid, 4-hydroxyphenyl ester
3-Isopropoxy-5-(trifluoromethoxy)phenylboronic acid
C10H12BF3O4 (264.07806980000004)
5-CHLORO-1-P-TOLYL-1H-PYRAZOLE-3-CARBOXYLICACIDETHYLESTER
Sulfaperin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
(R)-3-((BENZYLOXY)CARBONYL)-2-OXOIMIDAZOLIDINE-4-CARBOXYLIC ACID
5-[amino(methyl)amino]-4-chloro-2-(4-methylphenyl)pyridazin-3-one
Fluoro-N,N,N,N-tetramethylformamidinium hexafluorophosphate
2-(5-(TRIFLUOROMETHYL)-1H-INDOL-3-YL)ETHANAMINE HYDROCHLORIDE
ETHYL 1-(4-CHLOROPHENYL)-5-METHYL-1H-PYRAZOLE-3-CARBOXYLATE
(2R,3S)-1-CARBOXY-4-PENTYL-2,3-DIHYDROXYCYCLOHEXA-4,6-DIENE POTASSIUM SALT
methyl (E)-3-(4-methyl-1,3-thiazol-5-yl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate
(3-PROPOXY-5-(TRIFLUOROMETHOXY)PHENYL)BORONIC ACID
C10H12BF3O4 (264.07806980000004)
2-[4-(trifluoromethoxy)phenoxy]propanehydrazide
C10H11F3N2O3 (264.07217319999995)
Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride
2-[METHYL-2-NITRO-4-(TRIFLUOROMETHYL)ANILINO]ETHAN-1-OL
C10H11F3N2O3 (264.07217319999995)
4(3H)-Quinazolinone, 2-chloro-5-cyclobutyl-7-methoxy-
Urea,1-(8-hydroxy-2-methyl-4-oxo-3(4H)-quinazolinyl)-3-methyl-2-thio- (6CI)
1-(4-CHLOROPHENYL)-5-PROPYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
5-(2,5-Dioxotetrahydrofuryl)-3-Methyl-3-Cyclohexene-1,2-Dicarboxylic Anhydride
Temodox
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
2-Amino-2-(6-phenyl-3-pyridyl)acetic Acid Hydrochloride
2-Amino-2-[4-(2-pyridyl)phenyl]acetic Acid Hydrochloride
2-(8-Hydroxy-6-methoxy-1-oxo-1H-isochromen-3-yl)propionic acid
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C1971 - Angiogenesis Activator Inhibitor
Ozagrel hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D004791 - Enzyme Inhibitors
(1-Oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)methanethiosulfonate
2-Allyl-1-hydroxy-9,10-anthraquinone
R162 is a potent inhibitor of glutamate dehydrogenase 1 (GDH1/GLUD1), with anti-cancer properties.
2-Formamido-4-(2-formamidophenyl)-4-oxobutanoic acid
2-methoxy-N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]acetamide
4-chloro-N-(4-ethylphenyl)-3-methyl-5-isoxazolecarboxamide
1,3-dimethyl-6-[(2E)-2-(thiophen-2-ylmethylidene)hydrazinyl]pyrimidine-2,4(1H,3H)-dione
(3S)-3,7,8-trihydroxy-3-methyl-1,4-dihydropyrano[4,3-b]chromen-10-one
5-[(4-Hydroxyphenyl)diazenyl]-2,2-dimethyl-1,3-dioxane-4,6-dione
1,3-dimethyl-6-[2-(thiophen-2-ylmethylidene)hydrazinyl]pyrimidine-2,4-dione
Pozanicline (dihydrochloride)
Pozanicline dihydrochloride (ABT-089 dihydrochloride) is an orally bioavailable nicotinic acetylcholine receptor (nAChR) agonist with a Ki of 16.7 nM for binding to [3H]cytisine sites[1]. Pozanicline is an α4β2-selective nAChR agonist, which binds to rat brain α4β2 nAChR with a Ki of 17 nM while binding to α7 nAChR is insignificant[2].